Information  X 
Enter a valid email address

Virgin Money PLC (77LE)

  Print      Mail a friend

Thursday 28 March, 2019

Virgin Money PLC

Publication of Final Terms

RNS Number : 3336U
Virgin Money PLC
28 March 2019
 

RNS ANNOUNCEMENT

 

Publication of Final Terms

 

The following Final Terms under the €7 billion Global Covered Bond Programme of Virgin Money plc are available for viewing

 

£500,000,0000  Series 1 Floating Rate Covered Bonds due March 2024

 

The Final Terms should be read in conjunction with the prospectus dated 5 March 2019 relating to the Programme (the Prospectus).

To view the full Final Terms documents, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/3336U_1-2019-3-28.pdf

The Final Terms have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

 

For further information, please contact:

 

Lesley-Anne Johnson

Head of Debt Investor Relations

Virgin Money plc

Tel: +44 (0)191 279 4199

Email: [email protected]

For media, please contact:

 

CYBG Press Office

Tel: +44 (0)800 066 5998

Email: [email protected]

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed.  Prior to relying on the information contained in the Final Terms you must ascertain from the Final Terms whether or not you are part of the intended addressees of the information contained therein.

In particular, the Final Terms does not constitute an offer of securities for sale in the United States.  This is not for distribution in the United States.  The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements.  Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act.  There will be no public offering of the securities in the United States.

PROHIBITION OF SALES TO EEA RETAIL INVESTORS - The Covered Bonds are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (EEA). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, MiFID II); (ii) a customer within the meaning of Directive 2002/92/EC (as amended or superseded, the Insurance Mediation Directive), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Directive 2003/71/EC (as amended or superseded, the Prospectus Directive). Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended the PRIIPs Regulation) for offering or selling the Covered Bonds or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Covered Bonds or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation.

Your right to access this service is conditional upon complying with the above requirement.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PFTCKFDQKBKDQNB

a d v e r t i s e m e n t